Announcements Trials
Browse Landscape

Phase

Phase 2 103Phase 3 27Phase 1/2 22Phase 1 21Phase 2/3 6Phase NA 4Phase EARLY_PHASE1 4Phase 4 2

Status

Completed 12Unknown 7Not yet recruiting 3Terminated 2Recruiting 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Saline Solution 6Fentanyl 6Sodium Chloride 5Letrozole 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Fluorouracil × Clear all
NCT02688803 2025-12-04

OTT15-04

Ottawa Hospital Research Institute

Phase 4 Terminated
2 enrolled 4 charts
Breast

Breast Neoplasms

NCT02015650 2020-05-18

Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Medical University Innsbruck

Phase 4 Terminated
4 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡